期刊文献+

联合检测三项血清学指标对ACS患者PCI术后支架内再狭窄的预测作用 被引量:2

Predictive Value of Combined Detection of Three Serological Indicators for In-Stent Restenosis in Patients with ACS after PCI
原文传递
导出
摘要 目的探讨脂蛋白相关性磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2)、血清淀粉样蛋白A(serum amyloid A,SAA)、可溶性髓系细胞触发受体1(soluble triggering receptor expressed on myeloid cells-1,sTREM-1)联合检测对急性冠脉综合征(acute coronary syndrome,ACS)患者经皮冠脉介入术(percutaneous coronary intervention,PCI)后支架内再狭窄(in-stent restenosis,ISR)的预测作用。方法回顾分析2012年1月至2019年12月接受首次PCI治疗的ACS患者344例。根据患者PCI术后1年冠脉造影是否发生ISR,将患者分为再狭窄组(n=48)和非再狭窄组(n=296)。比较两组一般资料及实验室相关指标,采用逐步多元logistic回归分析PCI术后发生ISR危险因素,采用受试者操作特征(receiver operating characteristic,ROC)曲线评估Lp-PLA2、SAA、sTREM-1对ACS患者PCI术后发生ISR的预测效能。结果再狭窄组ST段抬高心肌梗死(ST segment elevation myocardial infarction,STEMI)比例、吸烟比例、低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)水平、糖化血红蛋白(glycosylated hemoglobin,HbA1c)水平、支架数目、分叉术式和支架串联比例高于非再狭窄组(P<0.05)。再狭窄组患者Lp-PLA2[(351.93±110.40)ng/ml vs(267.18±97.13)ng/ml)]、SAA[(19.83±4.39)mg/L vs(12.06±2.67)mg/L]、sTREM-1[(319.71±96.38)ng/L vs(238.92±80.35)ng/L]水平高于非再狭窄组(P<0.05)。STEMI、LDL-C、HbA1c未达标及Lp-PLA2、SAA、sTREM-1高表达、分叉术式是PCI术后发生ISR的独立危险因素(P<0.05)。以Lp-PLA2310.65 ng/ml、SAA 14.86 mg/L、sTREM-1293.79 ng/L为截断值,LpPLA2、SAA、sTREM-1联合诊断ACS的曲线下面积(area under the curve,AUC)为0.859,高于各指标单独诊断的AUC(Z=5.361,P<0.05)。结论ACS患者PCI术后ISR的发生与术后Lp-PLA2、SAA、sTREM-1高水平相关,联合检测可提升对ISR预测效能。 Objective To investigate the predictive value of lipoprotein-associated phospholipase A2(Lp-PLA2),serum amyloid A(SAA)and soluble triggering receptor expressed on myeloid cells-1(sTREM-1)for in-stent restenosis(ISR)in patients with acute coronary syndrome(ACS)after percutaneous coronary intervention(PCI).Methods Retrospective analysis was conducted on 344 patients with ACS who received initial PCI treatment from January 2012 to December 2019.The patients were divided into restenosis group(n=48)and non-restenosis group(n=296)according to whether ISR detected by coronary angiography 1 year after PCI.General data and laboratory indicators of the two groups were compared.Risk factors for ISR after PCI were analyzed by stepwise multiple logistic regression.Receiver operating characteristic(ROC)curve was used to evaluate the predictive efficacy of Lp-PLA2,SAA and sTREM-1 for ISR after PCI in patients with ACS.Results ST segment elevation myocardial infarction(STEMI)proportion,smoking proportion,low density lipoprotein-cholesterol(LDL-C)level,glycosylated hemoglobin(HbA1c)level,stent number,ratio of bifurcation operation and stent series in restenosis group were higher than those in non-restenosis group(P<0.05).The levels of Lp-PLA2[(351.93±110.40)ng/ml vs(267.18±97.13)ng/ml)],SAA[(19.83±4.39)mg/L vs(12.06±2.67)mg/L]and sTREM-1[(319.71±96.38)ng/L vs(238.92±80.35)ng/L]in the restenosis group were higher than those in the non-restenosis group(P<0.05).STEMI,LDL-C,Hb A1c,bifurcation operation,Lp-PLA2,SAA and s TREM-1 were independent risk factors for ISR after PCI(P<0.05).Using LpPLA2310.65 ng/ml,SAA 14.86 mg/L and s TREM-1293.79 ng/L as the cutoff values,the area under the curve(AUC)of combined diagnosis of Lp-PLA2,SAA and s TREM-1 was 0.859,which was higher than that of single diagnosis of each index(Z=5.361,P<0.05).Conclusions The occurrence of ISR after PCI in ACS patients is correlated with the high levels of Lp-PLA2,SAA and s TREM-1 after PCI,and the combined detection can improve the prediction efficiency of ISR.
作者 杨周静 张连超 朱世超 许高圻 安娜 YANG Zhoujing;ZHANG Lianchao;ZHU Shichao;XU Gaoqi;AN Na(Department of Cardiology,Bazhou Third Hospital,Bazhou 065700,Hebei,China)
出处 《中国分子心脏病学杂志》 CAS 2022年第4期4820-4826,共7页 Molecular Cardiology of China
基金 廊坊市科学技术研究与发展计划(2020013102)。
关键词 急性冠脉综合征 支架内再狭窄 经皮冠脉介入 脂蛋白相关性磷脂酶A2 血清淀粉样蛋白A 可溶性髓系细胞触发受体1 Acute coronary syndrome In-stent restenosis Percutaneous coronary intervention Lipoprotein-associated phospholipase A2 Serum amyloid A Soluble triggering receptor expressed on myeloid cells-1
  • 相关文献

参考文献11

二级参考文献53

  • 1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 2程亚萍,刘健.血清淀粉样蛋白A与冠状动脉粥样硬化性心脏病病理研究[J].医学综述,2007,13(18):1399-1400. 被引量:5
  • 3Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease [J ]. Circulation, 2006, 113 (2) 203-212.
  • 4Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J]. New Engl J Med, 2002, 346(23) : 1773-1780.
  • 5Zairis MN, Ambrose JA, Manousakis SJ, et al. The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stentingz The Global Evaluation of New Events and Restenosis After Stent Implantation Study[J]. J Am (2011 Cardiol, 2002, 40(8): 1375-1382.
  • 6Hansson GK. Inflammation, atherosclerosis, and coronary artery disease [J]. N Engl J Med, 2005, 352 (16): 1685-1695.
  • 7Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes [J ]. J Immunol, 2000, 164(10): 4991- 4995.
  • 8Gingras MC, Lapillonne H, Margolin JF. TREM1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development[J]. Mol Immunol, 2002, 38 (11): 817-824.
  • 9Veldsquez S, Matute JD, Gamez LY, et al. Characterization of nCD64 expression in neutrophils and levels of s-TREM-1 and HMGPrl in patients with suspected infection admitted in an emergency department[J]. Biomedica, 2013, 33(4): 643- 652.
  • 10Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1:its diagnostic accuracy in patients with suspected sepsis[J]. Ann Interrn Med, 2004, 141(1): 9 -15.

共引文献2055

同被引文献29

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部